A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- RANDOMIZED · PARALLEL · PREVENTION · TRIPLE
- Evidence population
- Human clinical study registration
- Participants
- 39
- Population
- ALL · 60 Years to 80 Years
- Duration
- 2022-09-01 to 2024-05-31
- Intervention
- Refined olive oil (38.6 mg hydroxytyrosol and tyrosol/kg oil); Virgin olive oil rich in phenolic compounds (156 mg hydroxytyrosol and tyrosol/kg oil); Maltodextrin; Prebiotic (FOS and inulin); Nutritional and physical activity recommendations
- Comparator
- Control group (Group A)
- Outcomes measured
- Change in muscle mass — Visit 1 (week 0), visit 5 (week 12), visit 6 (week 24); Body-weight — Visit 0 (week -1), visit 1 (week 0), visit 5 (week 12), visit 6 (week 24); Height — Visit 0 (week -1), visit 1 (week 0), visit 5 (week 12), visit 6 (week 24); Body Mass Index — Visit 0 (week -1), visit 1 (week 0), visit 5 (week 12), visit 6 (week 24); Body weight composition — Visit 0 (week -1), visit 1 (week 0), visit 5 (week 12), visit 6 (week 24); Waist circumference — Visit 0 (week -1), visit 1 (week 0), visit 5 (week 12), visit 6 (week 24); Sarcopenia assessment_skeletal muscle strength — Visit 0 (week -1), visit 1 (week 0), visit 5 (week 12), visit 6 (week…; Sarcopenia assessment_muscle mass — Visit 0 (week -1), visit 1 (week 0), visit 5 (week 12), visit 6 (week 24); Sarcopenia assessment_muscle physical performance — Visit 0 (week -1), visit 1 (week 0), visit 5 (week 12), visit 6 (we…; Compliance of physical activity recommendations — Visit 1 (week 0), visit 2 (week 3), visit 3 (week 6), visit 4 (week 9…; Compliance of the dietary recommendations — Visit 1 (week 0), visit 5 (week 12), visit 6 (week 24); Dietary compliance markers — Visit 1 (week 0), visit 5 (week 12), visit 6 (week 24); Specific phenolic compounds_dietary compliance markers — Visit 1 (week 0), visit 5 (week 12), visit 6 (week 24); Phenolic metabolites_dietary compliance markers — Visit 1 (week 0), visit 5 (week 12), visit 6 (week 24); Sarcopenia and Quality of life — Visit 1 (week 0), visit 5 (week 12), visit 6 (week 24); Fasting blood glucose (FBG) — Visit 1 (week 0), visit 5 (week 12), visit 6 (week 24); Insulin — Visit 1 (week 0), visit 5 (week 12), visit 6 (week 24); Homeostasis model assessment index (HOMA index) — Visit 1 (week 0), visit 5 (week 12), visit 6 (week 24); Lipid profile — Visit 1 (week 0), visit 5 (week 12), visit 6 (week 24); Apolipoproteins — Visit 1 (week 0), visit 5 (week 12), visit 6 (week 24)
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Sarcopenia · 100%Title contains controlled term: sarcopenia. Abstract contains controlled term: sarcopenia. Source terminology contains: sarcopenia. Title supplies longevity context: elderly. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.